(Q33964855)

English

Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

hypercholesterolemia

0 references

1 reference

based on heuristic

inferred from title

3

0 references

Joshua Barzilay

4

0 references

1

object named as

Mahboob Rahman

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Charles Baimbridge

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Jan N Basile

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Mario A Henriquez

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Anne Huml

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Nelson Kopyt

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Gail T Louis

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sara L Pressel

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Clive Rosendorff

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sithiporn Sastrasinh

12

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Carol Stanford

13

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ALLHAT Collaborative Research Group

14

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

3 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

American Journal of Kidney Diseases

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

412-424

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

5 July 2018

Meta-analysis: the effect of statins on albuminuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

5 July 2018

Statins for improving renal outcomes: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

5 July 2018

An overview of statin-associated proteinuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

5 July 2018

Effects of statins on renal function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

5 July 2018

Are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors renoprotective?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

5 July 2018

Effect of pravastatin on cardiovascular events in people with chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

5 July 2018

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

5 July 2018

The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

5 July 2018

Cholesterol and the risk of renal dysfunction in apparently healthy men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

5 July 2018

Study of Heart and Renal Protection (SHARP)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

5 July 2018

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

5 July 2018

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

5 July 2018

Effects of hypertension and dyslipidemia on the decline in renal function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

5 July 2018

In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

29 October 2018

Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

29 October 2018

Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLH

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

29 October 2018

Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

29 October 2018

Effect of a 3-year therapy with the 3-hydroxy-3-methylglutaryl coenzyme a reductase-inhibitor fluvastatin on endothelial function and distensibility of large arteries in hypercholesterolemic renal transplant recipient

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

29 October 2018

A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

29 October 2018

Effect of pravastatin on proteinuria in patients with well-controlled hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

29 October 2018

Effect of cerivastatin on proteinuria and urinary podocytes in patients with chronic glomerulonephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

29 October 2018

The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897819

29 October 2018

The effect of pravastatin on renal function and lipid metabolism in patients with renal dysfunction with hypertension and hyperlipidemia. Pravastatin and Renal Function Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18676075

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of treatment of dyslipidemia on renal function, fat deposits and scarring in patients with persistent nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/18676075

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18676075

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria

1 reference

https://pubmed.ncbi.nlm.nih.gov/18676075

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria

1 reference

https://pubmed.ncbi.nlm.nih.gov/18676075

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholesterol-lowering therapy may retard the progression of diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18676075

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective clinical trial comparing the treatment of idiopathic membranous nephropathy and nephrotic syndrome with simvastatin and diet, versus diet alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/18676075

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of albumin excretion rate in normotensive microalbuminuric type 2 diabetic patients during long-term simvastatin treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18676075

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18676075

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1053/J.AJKD.2008.05.027

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33964855&oldid=1739269524"